SMITH DAVID V (Executive Vice President & CFO) exercised options at FIVE PRIME THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/15/2020ACC: 0001209191-20-063391
Officer· Executive Vice President & CFO
Since Nov 2018
-11.50K
Net shares
Net seller
$185.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
22K acquired · 33.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22K
Price / share
—
Trade value
—
% of position
32.6%
12/11/2020
67.56K→89.56K
Common Stock
Direct
Shares
−11.50K
Price / share
$16.14
Trade value
$185.67K
% of position
12.8%
12/11/2020
89.56K→78.06K
Total
Net shares
+10.50K
Net value
-$185.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2020 | M · Option Exercise | +22K | — | — | 32.6% | 67.56K | 89.56K |
| Common Stock Direct | 12/11/2020 | F · Tax Withholding | −11.50K | $16.14 | $185.67K | 12.8% | 89.56K | 78.06K |
| Total | +10.50K | -$185.67K | ||||||
Derivative Transactions1
Performance-Based Restricted Common Stock
Direct
Converts to
Common Stock
22K shares
Shares
−22K
Strike price
Held after
0.00
Exercisable
—
12/11/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance-Based Restricted Common Stock Direct | Common Stock22K shares | 12/11/2020 | M · Option Exercise | −22K | — | 0.00 |